Bourdin, Claire, McGuigan, Christopher ![]() ![]() |
Abstract
7-Deazapurines are known to possess broad antiviral activity, however the 2’-C-methylguanosine analogue displays poor cell permeation and limited phosphorylation, thus is not an efficient inhibitor of hepatitis C virus (HCV) replication. We previously reported the 6-O-methyl entity as a prodrug moiety to increase liphophilicity of guanine nucleosides and the ProTide approach applied to 2’-C-methyl-6-O-methylguanosine has lead to potent HCV inhibitors now in clinical trials. In this paper, we report the synthesis and biological evaluation of 2’-C-methyl-6-O-methyl-7-deaza guanosine and ProTide derivatives. In contrast to prior studies, removal of the N-7 of the nucleobase entirely negates anti-HCV activity compared to the 2’-C-methyl-6-O-methylguanosine analogues. To understand better this significant loss of activity, enzymatic assays and molecular modeling were carried out and suggested 2’-C-methyl-6-O-methyl-7-deaza guanosine and related ProTides do not act as efficient prodrugs of the free nucleotide, in marked contrast to the case of the parent guanine analogue.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy Systems Immunity Research Institute (SIURI) |
Subjects: | Q Science > QR Microbiology > QR180 Immunology R Medicine > RM Therapeutics. Pharmacology |
Uncontrolled Keywords: | HCV; NS5b polymerase; 2’-C-methyl-6-O-methyl-7-deaza guanosine; ProTide; Phosphoramidate |
Publisher: | Elsevier |
ISSN: | 0960-894X |
Last Modified: | 05 Jan 2024 05:53 |
URI: | https://orca.cardiff.ac.uk/id/eprint/43410 |
Citation Data
Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |